Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12.
doi: 10.1097/HEP.0000000000001427. Online ahead of print.

Dissecting the liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure

Xia Yu  1 , Weihong Tian  2 , Xuanwen Bao  3 , Zhiwei Li  4   5 , Huilan Tu  1 , Xianbin Xu  1 , Jiyang Chen  1 , Quan Zhang  6 , Jianing Chen  1 , Chuan Liu  3 , Xiaomeng Dai  3 , Xinyi Xu  1 , Haoda Weng  1 , Yue Yu  1 , Xiuding Zhang  1 , Ruoqi Zhou  1 , Wenfeng Zhu  1 , Yan Lan  1 , Jinlin Cheng  1 , Min Xu  1 , Wei Wu  1 , Rui Huang  7   8 , Yida Yang  1 , Jifang Sheng  1 , Jing Guo  9 , Yu Shi  1
Affiliations

Dissecting the liver inflammation ecosystem identifies annexin A1 as a pro-resolving target for liver failure

Xia Yu et al. Hepatology. .

Abstract

Background and aims: Acute-on-chronic liver failure (ACLF) is driven by systemic inflammation and immune dysregulation. This study aims to characterize the immune landscape in ACLF and identify potential therapeutic targets.

Approach and results: We employed single-cell RNA sequencing, vision spatial sequencing, bulk RNA sequencing, and bioinformatics analysis to profile immune cells in ACLF livers compared to acute liver failure, decompensated cirrhosis, and controls. ACLF livers exhibited a distinct immune signature with increased neutrophils, particularly CCL4 + subsets, which drive unresolved inflammation by recruiting additional neutrophils and inflammatory CD14 + S100A9 + monocytes. Resident KCs were reduced, and monocytes differentiated into TREM2 + macrophages with an M1-like pro-inflammatory phenotype, exacerbating inflammation. Additionally, lymphoid cells showed significant dysfunction, with reduced NK cells and relatively expanded T cells exhibiting diminished cytotoxicity or pro-inflammatory cytokine production. Cell-cell communication analysis identified the ANXA1-FPR1 axis as a key interaction between T cells and myeloid cells, serving as a negative feedback mechanism to dampen inflammation. Plasma and hepatic ANXA1 levels were elevated in ACLF patients, correlating with disease severity. In the preclinical model, the ANXA1 peptide Ac2-26 improved liver function, reduced inflammation, and promoted macrophage polarization from M1 to M2. In vitro, Ac2-26 inhibited CCL4-mediated monocyte chemotaxis and M1 polarization, effects partially blocked by the FPR1 inhibitor Randialic acid B. Mechanically, Ac2-26 activated AMPK and inhibited mTOR signaling.

Conclusions: Our findings provide a comprehensive immune profile in ACLF and highlight ANXA1 as a potential therapeutic target for resolving immune dysregulation and improving outcomes in ACLF.

Keywords: liver failure; multi-omics; therapeutic target.

PubMed Disclaimer

References

    1. Arroyo V, Moreau R, Jalan R. Acute-on-chronic liver failure. N Engl J Med. 2020;382:2137–2145.
    1. Choudhury A, Kulkarni AV, Arora V, Soin AS, Dokmeci AK, Chowdhury A, et al. Acute-on-chronic liver failure (ACLF): The ‘Kyoto Consensus’-steps from Asia. Hepatol Int. 2025;19:1–69.
    1. Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, et al. Global burden of disease: Acute-on-chronic liver failure, a systematic review and meta-analysis. Gut. 2022;71:148–155.
    1. Br VK, Sarin SK. Acute-on-chronic liver failure: Terminology, mechanisms and management. Clin Mol Hepatol. 2023;29:670–689.
    1. Engelmann C, Zhang IW, Clària J. Mechanisms of immunity in acutely decompensated cirrhosis and acute-on-chronic liver failure. Liver Int. 2025;45:e15644.

LinkOut - more resources